These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 37544725)
41. Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Taylor J; Mi X; North K; Binder M; Penson A; Lasho T; Knorr K; Haddadin M; Liu B; Pangallo J; Benbarche S; Wiseman D; Tefferi A; Halene S; Liang Y; Patnaik MM; Bradley RK; Abdel-Wahab O Blood; 2020 Sep; 136(13):1477-1486. PubMed ID: 32640014 [TBL] [Abstract][Full Text] [Related]
42. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts. Kang MG; Kim HR; Seo BY; Lee JH; Choi SY; Kim SH; Shin JH; Suh SP; Ahn JS; Shin MG BMC Cancer; 2015 Jun; 15():484. PubMed ID: 26115659 [TBL] [Abstract][Full Text] [Related]
43. Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal. Xu JJ; Smeets MF; Tan SY; Wall M; Purton LE; Walkley CR Exp Hematol; 2019 Feb; 70():10-23. PubMed ID: 30408513 [TBL] [Abstract][Full Text] [Related]
44. Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Maciejewski JP; Padgett RA Br J Haematol; 2012 Jul; 158(2):165-173. PubMed ID: 22594801 [TBL] [Abstract][Full Text] [Related]
45. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability. Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405 [TBL] [Abstract][Full Text] [Related]
46. Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia. Chesnais V; Kosmider O; Damm F; Itzykson R; Bernard OA; Solary E; Fontenay M Oncotarget; 2012 Nov; 3(11):1284-93. PubMed ID: 23327988 [TBL] [Abstract][Full Text] [Related]
47. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia. Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291 [TBL] [Abstract][Full Text] [Related]
53. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia. Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135 [TBL] [Abstract][Full Text] [Related]
54. GPATCH8 modulates mutant SF3B1 mis-splicing and pathogenicity in hematologic malignancies. Benbarche S; Pineda JMB; Galvis LB; Biswas J; Liu B; Wang E; Zhang Q; Hogg SJ; Lyttle K; Dahi A; Lewis AM; Sarchi M; Rahman J; Fox N; Ai Y; Mehta S; Garippa R; Ortiz-Pacheco J; Li Z; Monetti M; Stanley RF; Doulatov S; Bradley RK; Abdel-Wahab O Mol Cell; 2024 May; 84(10):1886-1903.e10. PubMed ID: 38688280 [TBL] [Abstract][Full Text] [Related]
55. Mutations of RNA splicing factors in hematological malignancies. Shukla GC; Singh J Cancer Lett; 2017 Nov; 409():1-8. PubMed ID: 28888996 [TBL] [Abstract][Full Text] [Related]
56. Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring Cheruiyot A; Li S; Nonavinkere Srivatsan S; Ahmed T; Chen Y; Lemacon DS; Li Y; Yang Z; Wadugu BA; Warner WA; Pruett-Miller SM; Obeng EA; Link DC; He D; Xiao F; Wang X; Bailis JM; Walter MJ; You Z Cancer Res; 2021 Sep; 81(17):4499-4513. PubMed ID: 34215620 [TBL] [Abstract][Full Text] [Related]
57. Pan-cancer analysis identifies mutations in Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164 [TBL] [Abstract][Full Text] [Related]
58. Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia. Zhou J; Chng WJ Stem Cell Investig; 2017; 4():6. PubMed ID: 28217708 [TBL] [Abstract][Full Text] [Related]
59. Therapeutic approaches to treat human spliceosomal diseases. DeNicola AB; Tang Y Curr Opin Biotechnol; 2019 Dec; 60():72-81. PubMed ID: 30772756 [TBL] [Abstract][Full Text] [Related]
60. Therapeutic targeting of RNA splicing in myelodysplasia. Kim YJ; Abdel-Wahab O Semin Hematol; 2017 Jul; 54(3):167-173. PubMed ID: 28958291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]